Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai, +9

Cancer Chemotherapy and Pharmacology

Dose-escalation StudyRadiation MedicineMedicineMetronomic TherapyAdvanced Solid Tumours +8

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors

Kenji Tamura, Jun Hashimoto, Yuko Tanabe, +11

Cancer Chemotherapy and Pharmacology

Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer

Akitaka Makiyama, Kohei Arimizu, Gen Hirano, +17

Gastric Cancer

Irinotecan MonotherapySurgical OncologyGastrointestinal OncologyAdvanced Gastric CancerMedicine +7

B cell activation regulates exosomal HLA production

Shuji Arita, Eishi Baba, Yoshihiro Shibata, +6

European Journal of Immunology

Human STEAP3 maintains tumor growth under hypoferric condition

Taichi Isobe, Eishi Baba, Shuji Arita, +8

Experimental Cell Research

Tumor BiologyHuman Steap3PathologyMedicineCancer Growth +2

<scp>PD</scp>‐1+ <scp>TIM</scp>‐3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer

Michitaka Nakano, Mamoru Ito, Risa Tanaka, +14

Cancer Science

ImmunologyPathologyImmunotherapyTumor BiologyOncology +17

Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus

Kyoko Inadomi, Hozumi Kumagai, Shuji Arita, +17

Medicine

Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer

Kotoe Takayoshi, Hitoshi Kusaba, Masato Uenomachi, +14

Cancer Chemotherapy and Pharmacology

OncologyGastrointestinal OncologyCancer ManagementPathologyCancer Treatment +3

Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer.

Yoko Harima, K Harima, Shintaro Sawada, +3

PubMed

CytogeneticsGeneticsPathologyGynecologyTumor Biology +17

Pancreatic acinar cell carcinoma presenting with panniculitis, successfully treated with FOLFIRINOX: A case report

Tomoyasu Yoshihiro, Kenta Nio, Kenji Tsuchihashi, +14

Molecular and Clinical Oncology